AmerisourceBergen (NYSE: ABC – Get Rating) had its target price decreased by investment analysts at Cowen from $ 171.00 to $ 170.00 in a report released on Thursday, Stock Target Advisor reports. The firm currently has an “outperform” rating on the stock. Cowen’s price target indicates a potential upside of 17.69% from the company current price.
Several other brokerages have also recently weighed in on ABC. Deutsche Bank Aktiengesellschaft raised AmerisourceBergen from a “hold” rating to a “buy” rating and upped their price target for the stock from $ 167.00 to $ 178.00 in a research note on Tuesday. Argus increased their price objective on AmerisourceBergen from $ 140.00 to $ 160.00 in a research report on Monday, March 14th. Evercore ISI lowered their target price on AmerisourceBergen to $ 165.00 in a report on Friday, June 3rd. StockNews.com raised AmerisourceBergen from a “buy” rating to a “strong-buy” rating in a report on Friday, May 6th. Finally, Barclays raised AmerisourceBergen from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $ 175.00 to $ 182.00 in a research note on Thursday, May 26th. Three analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $ 169.40.
Shares of NYSE ABC opened at $ 144.45 on Thursday. AmerisourceBergen has a 12 month low of $ 111.34 and a 12 month high of $ 167.19. The company has a current ratio of 0.92, a quick ratio of 0.56 and a debt-to-equity ratio of 5.13. The firm has a market capitalization of $ 30.26 billion, a price-to-earnings ratio of 17.62, a PEG ratio of 1.66 and a beta of 0.45. The business has a 50-day moving average of $ 155.62 and a 200-day moving average of $ 143.05.
AmerisourceBergen (NYSE: ABC – Get Rating) last released its earnings results on Wednesday, May 4th. The company reported $ 3.22 earnings per share for the quarter, topping analysts’ consensus estimates of $ 2.99 by $ 0.23. AmerisourceBergen had a return on equity of 349.46% and a net margin of 0.75%. The company had revenue of $ 57.72 billion during the quarter, compared to the estimate consensus of $ 57.26 billion. During the same quarter in the previous year, the company posted $ 2.53 EPS. AmerisourceBergen’s quarterly revenue was up 17.4% compared to the same quarter last year. On average, analysts predict that AmerisourceBergen will post 10.95 earnings per share for the current year.
In other news, CAO Lazarus Krikorian sold 4,895 shares of AmerisourceBergen stock in a transaction that occurred on Wednesday, May 11th. The stock was sold at an average price of $ 160.00, for a total value of $ 783,200.00. Following the completion of the transaction, the chief accounting officer now owns 14,079 shares in the company, valued at approximately $ 2,252,640. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Gina Clark sold 43,704 shares of AmerisourceBergen stock in a transaction that occurred on Monday, March 28th. The stock was sold at an average price of $ 153.71, for a total value of $ 6,717,741.84. The disclosure for this sale can be found here. Insiders have sold 6,066,899 shares of company stock valued at $ 910,384,692 in the last quarter. 28.40% of the stock is currently owned by company insiders.
Several institutional investors have recently made changes to their positions in the company. LPL Financial LLC lifted its stake in shares of AmerisourceBergen by 13.4% during the 3rd quarter. LPL Financial LLC now owns 134,156 shares of the company stock worth $ 16,025,000 after acquiring an additional 15,901 shares during the last quarter. Fiera Capital Corp lifted its stake in shares of AmerisourceBergen by 12.5% during the 4th quarter. Fiera Capital Corp now owns 3,300 shares of the company stock worth $ 439,000 after acquiring an additional 367 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its stake in shares of AmerisourceBergen by 6.1% during the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 470,443 shares of the company stock worth $ 62,517,000 after acquiring an additional 26,996 shares during the last quarter. Maverick Capital Ltd. bought a new stake in shares of AmerisourceBergen during the 3rd quarter worth approximately $ 1,789,000. Finally, Renaissance Technologies LLC lifted its stake in shares of AmerisourceBergen by 11,356.5% during the 4th quarter. Renaissance Technologies LLC now owns 234,400 shares of the company stock worth $ 31,149,000 after acquiring an additional 232,354 shares during the last quarter. Hedge funds and other institutional investors own 64.17% of the company stock.
AmerisourceBergen Company Profile: (Get Rating)
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
Featured Articles:
Receive News & Ratings for AmerisourceBergen Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AmerisourceBergen and related companies with MarketBeat.com’s FREE daily email newsletter.
AmerisourceBergen (NYSE: ABC – Get Rating) had its price objective cut by equities research analysts at Cowen from $ 171.00 to $ 170.00 in a note issued to investors on Thursday, The Fly reports. Cowen’s price objective would indicate a potential upside of 17.69% from the stock’s current price.
Several other research analysts also recently commented on the stock. Argus lifted their price target on shares of AmerisourceBergen from $ 140.00 to $ 160.00 in a research note on Monday, March 14th. Evercore ISI decreased their price target on shares of AmerisourceBergen to $ 165.00 in a research note on Friday, June 3rd. Barclays raised shares of AmerisourceBergen from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $ 175.00 to $ 182.00 in a research note on Thursday, May 26th. Robert W. Baird lifted their price target on shares of AmerisourceBergen from $ 179.00 to $ 187.00 in a research note on Thursday, May 5th. Finally, Mizuho lifted their price target on shares of AmerisourceBergen from $ 139.00 to $ 162.00 in a research note on Thursday, May 5th. Three investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $ 169.40.
Shares of NYSE: ABC opened at $ 144.45 on Thursday. The company has a quick ratio of 0.56, a current ratio of 0.92 and a debt-to-equity ratio of 5.13. The firm has a market capitalization of $ 30.26 billion, a PE ratio of 17.62, a P / E / G ratio of 1.66 and a beta of 0.45. AmerisourceBergen has a twelve month low of $ 111.34 and a twelve month high of $ 167.19. The company has a 50-day moving average price of $ 155.62 and a two-hundred day moving average price of $ 143.05.
AmerisourceBergen (NYSE: ABC – Get Rating) last released its quarterly earnings data on Wednesday, May 4th. The company reported $ 3.22 EPS for the quarter, beating analysts’ consensus estimates of $ 2.99 by $ 0.23. AmerisourceBergen had a net margin of 0.75% and a return on equity of 349.46%. The company had revenue of $ 57.72 billion during the quarter, compared to analyst estimates of $ 57.26 billion. During the same period last year, the business earned $ 2.53 earnings per share. AmerisourceBergen’s revenue was up 17.4% compared to the same quarter last year. Analysts anticipate that AmerisourceBergen will post 10.95 earnings per share for the current fiscal year.
In other news, EVP Silvana Battaglia sold 6,820 shares of the business’s stock in a transaction on Tuesday, March 15th. The shares were sold at an average price of $ 149.96, for a total transaction of $ 1,022,727.20. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CAO Lazarus Krikorian sold 4,895 shares of the business’s stock in a transaction on Wednesday, May 11th. The shares were sold at an average price of $ 160.00, for a total transaction of $ 783,200.00. Following the sale, the chief accounting officer now owns 14,079 shares in the company, valued at approximately $ 2,252,640. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,066,899 shares of company stock worth $ 910,384,692. Company insiders own 28.40% of the company stock.
A number of institutional investors have recently made changes to their positions in ABC. LPL Financial LLC raised its position in AmerisourceBergen by 13.4% in the 3rd quarter. LPL Financial LLC now owns 134,156 shares of the company stock worth $ 16,025,000 after buying an additional 15,901 shares during the last quarter. Fiera Capital Corp raised its position in AmerisourceBergen by 12.5% in the 4th quarter. Fiera Capital Corp now owns 3,300 shares of the company stock worth $ 439,000 after buying an additional 367 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its position in AmerisourceBergen by 6.1% in the 4th quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 470,443 shares of the company stock worth $ 62,517,000 after buying an additional 26,996 shares during the last quarter. Maverick Capital Ltd. purchased a new position in AmerisourceBergen in the 3rd quarter worth about $ 1,789,000. Finally, Renaissance Technologies LLC raised its position in AmerisourceBergen by 11,356.5% in the 4th quarter. Renaissance Technologies LLC now owns 234,400 shares of the company stock worth $ 31,149,000 after buying an additional 232,354 shares during the last quarter. Institutional investors own 64.17% of the company stock.
AmerisourceBergen Company Profile: (Get Rating)
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
Featured Articles:
Receive News & Ratings for AmerisourceBergen Daily: – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AmerisourceBergen and related companies with MarketBeat.com’s FREE daily email newsletter.
.